Price$68.61-0.91 (-1.31%)
02:30 PM07:45 PM
News · 26 weeks37-22%
2025-10-262026-04-19
Mix2190d
- Insider7(33%)
- SEC Filings6(29%)
- Earnings3(14%)
- Other3(14%)
- Analyst2(10%)
Latest news
25 items- SECMerit Medical Systems Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)
- PRMerit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2026, after the close of the stock market on Thursday, April 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, April 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific). To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details. A live webcast and slide deck can be accessed using this link. A link to bo
- INSIDERSEC Form 4 filed by Lampropoulos Fred P.4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)
- SECMerit Medical Systems Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)
- PRMerit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology PortfolioSOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark® Detection Imaging System and OneMark Tissue Markers. The aggregate transaction consideration, including the assumption of ViewPoint liabilities, is approximately $140 million. Of that amount, $90 million was paid in cash at closing and two deferred payments of $25 million each are scheduled to be paid not later than the first and
- SECSEC Form DEFA14A filed by Merit Medical Systems Inc.DEFA14A - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)
- SECSEC Form DEF 14A filed by Merit Medical Systems Inc.DEF 14A - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Merit Medical Systems Inc.SCHEDULE 13G/A - MERIT MEDICAL SYSTEMS INC (0000856982) (Subject)
- PRMedtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back painExclusive agreement expands Medtronic's comprehensive pain interventions portfolio, increases treatment options for patients living with chronic pain GALWAY, Ireland, March 24, 2026 /PRNewswire/ -- Medtronic plc, a global leader in healthcare technology, today announced that it has entered into a distribution agreement with Merit Medical Systems, Inc. (NASDAQ:MMSI), to offer FDA-cleared ViaVerte™ — a minimally invasive and implant free basivertebral nerve ablation (BVNA) system. It is the first and only BVNA system with a physician-controlled steerable mechanism for precise basivertebral nerve targeting for treating chronic vertebrogenic lower back pain. This agreement continues Medtronic's
- PRMerit Medical Launches the Resilience Through-the-Scope Esophageal StentSOUTH JORDAN, Utah, March 16, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced the US commercial release of the Resilience Through-the-Scope (TTS) Esophageal Stent. The Resilience stent is the newest product in Merit's Endoscopy portfolio, joining a comprehensive offering of treatment options for patients with disease in the esophagus. The new stent is indicated for treatment of esophageal fistulas and strictures (narrowing) caused by malignant tumors. Esophageal cancer is the sixth most common cause of cancer deaths worldwide.1 Symptoms of esophageal cancer include trouble swallowing, regurgitation, and chest p
- INSIDERCHIEF LEGAL OFFICER, SECRETARY Lloyd Brian G. was granted 33,665 shares and covered exercise/tax liability with 5,778 shares, increasing direct ownership by 81% to 62,132 units (SEC Form 4)4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)
- INSIDERCHIEF OPERATING OFFICER Peterson Neil W. was granted 24,692 shares and covered exercise/tax liability with 6,061 shares, increasing direct ownership by 66% to 47,000 units (SEC Form 4)4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)
- INSIDERPresident and CEO Aronson Martha Goldberg was granted 28,198 shares, increasing direct ownership by 144% to 47,792 units (SEC Form 4)4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)
- INSIDERCHIEF HUMAN RESOURCES OFFICER Voigt Michel J. covered exercise/tax liability with 6,698 shares and was granted 31,101 shares, increasing direct ownership by 112% to 46,127 units (SEC Form 4)4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)
- INSIDERChief Commercial Officer Smith Christian Adam was granted 21,374 shares and covered exercise/tax liability with 2,018 shares, increasing direct ownership by 176% to 30,334 units (SEC Form 4)4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)
- INSIDERCFO AND TREASURER Parra Raul Jr. was granted 38,920 shares and covered exercise/tax liability with 5,778 shares, increasing direct ownership by 137% to 57,343 units (SEC Form 4)4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)
- ANALYSTMerit Medical downgraded by Wells Fargo with a new price targetWells Fargo downgraded Merit Medical from Overweight to Equal Weight and set a new price target of $78.00
- SECSEC Form 10-K filed by Merit Medical Systems Inc.10-K - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)
- SECMerit Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)
- PRMerit Medical Reports Fourth Quarter and Full Year 2025 Results and Issues Fiscal Year 2026 GuidanceFourth Quarter Highlights† Reported revenue of $393.9 million, up 11%Constant currency revenue* and constant currency revenue, organic* up 10% and up 7%, respectivelyGAAP operating margin of 13.8%, compared to 10.3% in prior year periodNon-GAAP operating margin* of 21.0%, compared to 19.6% in prior year periodGAAP EPS $0.63, up 37%Non-GAAP EPS* $1.04, up 12%Free cash flow* generation of $74.0 million, up 13% Fiscal Year 2025 Highlights† Reported revenue of $1.516 billion, up 12%Constant currency revenue* and constant currency revenue, organic* up 11% and up 7%, respectivelyGAAP operating margin of 12.2%, compared to 11.5% in prior yearNon-GAAP operating margin* of 20.3%, compared to 19.0%
- ANALYSTBTIG Research initiated coverage on Merit Medical with a new price targetBTIG Research initiated coverage of Merit Medical with a rating of Buy and set a new price target of $107.00
- SECMerit Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits8-K - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)
- PRMerit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit's Lead Independent Director, as Chair of the Board effective January 5, 2026. Dr. Millner has served as a director of Merit since 2015 and as the Lead Independent Director since July 2021. She previously served as the Chair of Merit's Governance and Sustainability Committee. Dr. Millner currently serves as a member of the Utah State Senate, to which she was elected in 2015. She served as the President of Weber State University from 2002 through 2012
- INSIDERCHIEF OPERATING OFFICER Peterson Neil W. exercised 5,000 shares at a strike of $54.40 and sold $450,000 worth of shares (5,000 units at $90.00) (SEC Form 4)4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)
- PRMerit Medical to Participate at the J.P. Morgan Healthcare ConferenceSOUTH JORDAN, Utah, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced that management will participate in the 44th Annual J.P. Morgan Healthcare Conference, which is being held at The Westin St. Francis Hotel in San Francisco, California, January 12-15, 2026. To learn more, visit Healthcare Conference. Martha G. Aronson, President and Chief Executive Officer, and Raul Parra, Chief Financial Officer, will present a company overview and update on Tuesday, January 13th at 4:30 pm Pacific Time / 7:30 pm Eastern Time. Presentation materials for the conference will be posted to Merit's investor relations websi